Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

NCT02441686

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Eastern Maine Medical Center Brewer, Maine, United States
  • Massachusetts General Hosptial Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

NCT06236061

Conditions
Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hypertension, +10 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
View all 43 locations
View Trial Details
Completed

Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT03702725

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Loyola University Medical Center Maywood, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
  • The Ohio State University Wexner Medical Center/James Cancer Hospital Columbus, Ohio, United States
View Trial Details
Completed

WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

NCT05678998

Conditions
Advanced or Metastatic Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Emory Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details

Related conditions